Results 141 to 150 of about 353,583 (326)

Comparative analysis on characteristics of two activated partial thromboplastin time reagents. [PDF]

J Clin Lab Anal, 2022
Yasui Y, Ishii T, Tatebe J, Morita T.
europepmc   +1 more source

Comparison of Hemostatic Activity in Canine Leukoreduced Cryoprecipitate, Cryopoor Plasma, and Fresh Plasma

Veterinary Clinical Pathology, EarlyView.
ABSTRACT Background To date, no studies have reported the evaluation of hemostatic activity in canine leukoreduced cryoprecipitate (LR‐CRYO) and leukoreduced cryopoor plasma (LR‐CPP). Objectives We aimed to compare the hemostatic activity of LR‐CRYO and LR‐CPP to leukoreduced fresh plasma (LR‐FP) and to evaluate the preservation of LR‐CRYO by ...
Roberta Perego, Eva Spada, Luciana Baggiani, Giuliano Ravasio, Enrica Zucca, Graziella Vanosi, Giancarlo Ruffo, Daniela Proverbio   +7 more
wiley   +1 more source

A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies. [PDF]

Intern Med, 2023
Tsukamoto Y, Sugimoto T, Umeda M, Kato T, Hiura Y, Morita K, Ariyoshi K.   +6 more
europepmc   +1 more source

The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): Interference of C‐reactive protein

Journal of clinical laboratory analysis (Print), 2018
Jie Liu, Fanfan Li, K. Shu, Tao Chen, Xiaoou Wang, Yaoqi Xie, Shanshan Li, Zhaohua Zhang, S. Jin, M. Jiang   +9 more
semanticscholar   +1 more source

Development of Reference Intervals for the TEG 6s, a Point‐of‐Care Viscoelastic Assay, in Dogs

Veterinary Clinical Pathology, EarlyView.
ABSTRACT Background Thromboelastography (TEG) provides a global assessment of hemostasis and identifies patients with both hemorrhagic and thrombotic tendencies. Traditional TEG instruments, such as the TEG 5000 (Haemonetics), can be labor‐intensive and require specialized training to operate.
Ashley R. Wilkinson, Bobbi J. Conner, Priscila B. S. Serpa   +2 more
wiley   +1 more source

Activated Partial Thromboplastin Time and Risk of Future Venous Thromboembolism [PDF]

, 2008
Neil A. Zakai, Tetsuya Ohira, Richard White, Aaron R. Folsom, Mary Cushman   +4 more
openalex   +3 more sources

Comparison of Time Within Therapeutic Range Using Anti-Factor Xa Versus Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin in Children. [PDF]

J Pediatr Pharmacol Ther, 2023
Haftmann RJ, Pineda EM, Hall BA, Wilson MD, Mateev SN.   +4 more
europepmc   +1 more source

Comparing a piezoelectric quartz crystal with an optical coagulometer in monitoring high-dose heparin therapy by determining whole blood activated partial thromboplastin time and activated clotting time [PDF]

, 2005
Tsun‐Mei Lin, Tzong‐Jih Cheng, Tsui-Hsun Wu, Hsien‐Chang Chang   +3 more
openalex   +1 more source

An experimental comparison and user evaluation of three different dried plasma products

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Access to blood components in pre‐hospital bleeding resuscitation is challenging. Dried plasma is a logistically superior alternative, and new products are emerging. Therefore, we aimed to evaluate laboratory and practical differences in three differently produced dried plasma products.
Kristina Ehn, Gabriel Skallsjö, Birgitta Romlin, Göran Sandström, Per Sandgren, Agneta Wikman   +5 more
wiley   +1 more source

Changes in Some Haemostatic Parameters Among Patients with Chronic Kidney Disease in Kano Metropolis

Sokoto Journal of Medical Laboratory Science, 2017
It has long been accepted that Chronic Kidney Disease (CKD) causes alterations in haemostatic parameters.  These changes have not been reported in our community.
Usman, M. D., *Garba, N., Danladi, S.B., Isah, S.Y., Audu, A., Dakata A.M., and Jelani, I.
doaj